2,329
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Predicting menstrual bleeding patterns with levonorgestrel-releasing intrauterine systems

, , , & ORCID Icon
Pages 48-57 | Received 30 Apr 2020, Accepted 23 Oct 2020, Published online: 03 Dec 2020

References

  • Committee on Gynecologic Practice Long-Acting Reversible Contraception Working Group. Committee opinion No. 642: increasing access to contraceptive implants and intrauterine devices to reduce unintended pregnancy. Obstet Gynecol. 2015;126:e44.
  • Winner B, Peipert JF, Zhao Q, et al. Effectiveness of long-acting reversible contraception. N Engl J Med. 2012;366(21):1998–2007.
  • Trussell J. Contraceptive failure in the United States. Contraception. 2011;83(5):397–404.
  • Polis CB, Hussain R, Berry A. There might be blood: a scoping review on women's responses to contraceptive-induced menstrual bleeding changes. Reprod Health. 2018;15(1):114.
  • Tolley E, Loza S, Kafafi L, et al. The impact of menstrual side effects on contraceptive discontinuation: findings from a longitudinal study in Cairo, Egypt. Int Fam Plan Perspect. 2005;31(1):15–23.
  • Mansour D, Korver T, Marintcheva-Petrova M, et al. The effects of Implanon on menstrual bleeding patterns. Eur J Contracept Reprod Health Care. 2008;13(sup1):13–28.
  • Diedrich JT, Desai S, Zhao Q, et al. Association of short-term bleeding and cramping patterns with long-acting reversible contraceptive method satisfaction. Am J Obstet Gynecol. 2015;212(1):50.e1.
  • Foran T. The management of irregular bleeding in women using contraception. Aust Fam Physician. 2017;46(10):717–720.
  • Godfrey EM, Folger SG, Jeng G, et al. Treatment of bleeding irregularities in women with copper-containing IUDs: a systematic review. Contraception. 2013;87(5):549–566.
  • Krishnamoorthy K, Verma U. Chapter 1. Intrauterine devices (IUD): clinical aspects, side effects and potential complications. In: Berhardt LV, editor. Advances in medicine and biology. Vol. 120. Hauppauge (NY): Nova Biomedical; 2017. p. 1–23.
  • Andersson K, Odlind V, Rybo G. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial. Contraception. 1994;49(1):56–72.
  • Bednarek PH, Jensen JT. Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-IUS. Int J Womens Health. 2010;1:45–58.
  • Gemzell-Danielsson K, Schellschmidt I, Apter D. A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena. Fertil Steril. 2012;97(3):616.e3–622.e3.
  • Gemzell-Danielsson K, Apter D, Dermout S, et al. Evaluation of a new, low-dose levonorgestrel intrauterine contraceptive system over 5 years of use. Eur J Obstet Gynecol Reprod Biol. 2017;210:22–28.
  • Nelson AL. LNG-IUS 12: a 19.5 levonorgestrel-releasing intrauterine system for prevention of pregnancy for up to five years. Expert Opin Drug Deliv. 2017;14(9):1131–1140.
  • Jensen J, Mansour D, Lukkari-Lax E, et al. Bleeding patterns with the levonorgestrel-releasing intrauterine system when used for heavy menstrual bleeding in women without structural pelvic pathology: a pooled analysis of randomized controlled studies. Contraception. 2013;87(1):107–112.
  • Beckert V, et al. Bleeding patterns with the 19.5 mg LNG-IUS, with special focus on the first year of use: implications for counselling. Eur J Contracept Reprod Health Care. 2019;24(4):251–259.
  • Merki-Feld GS, Caetano C, Porz TC, et al. Are there unmet needs in contraceptive counselling and choice? Findings of the European TANCO Study. Eur J Contracept Reprod Health Care. 2018;23(3):183–193.
  • Borgatta L, Buhling KJ, Rybowski S, et al. A multicentre, open-label, randomised phase III study comparing a new levonorgestrel intrauterine contraceptive system (LNG-IUS 8) with combined oral contraception in young women of reproductive age. Eur J Contracept Reprod Health Care. 2016;21(5):372–379.
  • Weisberg E, Bateson D, McGeechan K, et al. A three-year comparative study of continuation rates, bleeding patterns and satisfaction in Australian women using a subdermal contraceptive implant or progestogen releasing-intrauterine system. Eur J Contracept Reprod Health Care. 2014;19(1):5–14.
  • Carvalho NM, Chou V, Modesto W, et al. Relationship between user satisfaction with the levonorgestrel-releasing intrauterine system and bleeding patterns. J Obstet Gynaecol Res. 2017;43(11):1732–1737.
  • Clark LR, Barnes-Harper KT, Ginsburg KR, et al. Menstrual irregularity from hormonal contraception: a cause of reproductive health concerns in minority adolescent young women. Contraception. 2006;74(3):214–219.
  • Dehlendorf C, Levy K, Kelley A, et al. Women's preferences for contraceptive counseling and decision making. Contraception. 2013;88(2):250–256.
  • Dehlendorf C, Krajewski C, Borrero S. Contraceptive counseling: best practices to ensure quality communication and enable effective contraceptive use. Clin Obstet Gynecol. 2014;57(4):659–673.
  • Diamond-Smith N, Campbell M, Madan S. Misinformation and fear of side-effects of family planning. Cult Health Sex. 2012;14(4):421–433.
  • Gerlinger C, Wessel J, Kallischnigg G, et al. Pattern recognition in menstrual bleeding diaries by statistical cluster analysis. BMC Womens Health. 2009;9:21.
  • Schumacher U, Schumacher J, Mellinger U, et al. Estimation of menstrual blood loss volume based on menstrual diary and laboratory data. BMC Womens Health. 2012;12:24.
  • Li S, Lee H. Learning daily activity patterns with probabilistic grammars. Transportation. 2017;44(1):49–68.
  • Hafezi MH, Liu L, Millward H. Identification of representative patterns of time use activity through fuzzy C-means clustering. Transp Res Rec. 2017;2668(1):38–50.
  • Hafezi MH, Liu L, Millward H. A time-use activity-pattern recognition model for activity-based travel demand modeling. Transportation. 2019;46(4):1369–1349.
  • Allahviranloo M, Recker W. Daily activity pattern recognition by using support vector machines with multiple classes. Transp Res Part B. 2013;58:16–43.
  • Nelson A, Apter D, Hauck B, et al. Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial. Obstet Gynecol. 2013;122(6):1205–1213.
  • Gerlinger C, Endrikat J, Kallischnigg G, et al. Evaluation of menstrual bleeding patterns: a new proposal for a universal guideline based on the analysis of more than 4500 bleeding diaries. Eur J Contracept Reprod Health Care. 2007;12(3):203–211.
  • Belsey EM, Machin D, d'Arcangues C. The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction. Contraception. 1986;34(3):253–260.
  • Fraser IS, Critchley HO, Broder M, et al. The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding. Semin Reprod Med. 2011;29.(5):383–390.
  • Breiman L. Random forests. Mach Learn. 2001;45(1):5–32.
  • Abraham GE. The normal menstrual cycle. In: Givens JR, editor. Endocrine causes of menstrual disorders. Chicago (IL): Year Book Medical Publishers, Inc.; 1978. p. 15–44.
  • Rokach L, Maimon O. Data mining with decision trees: theory and applications. 2nd ed. Vol. 69. London: World Scientific; 2008.
  • Hastie TJ, Tibshirani RJ, Friedman JH. The elements of statistical learning: data mining, inference, and prediction. 2nd ed. New York: Springer-Verlag; 2009.
  • Villavicencio J, Allen RH. Unscheduled bleeding and contraceptive choice: increasing satisfaction and continuation rates. Open Access J Contracept. 2016;7:43–52.
  • Dehlendorf C, Fitzpatrick J, Steinauer J, et al. Development and field testing of a decision support tool to facilitate shared decision making in contraceptive counseling. Patient Educ Couns. 2017;100(7):1374–1381.